WEHI researchers have visualised a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from spreading.

A depiction of proteins Pfs230 and Pfs48/45 bound together. This binding process is crucial for the malaria parasite’s ability to fertilise and spread. Australian researchers have visualised a key ...

WEHI researchers have visualized a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from spreading.

From Moscow to Boston, these two molecular biologists built their lives and careers together studying RNA in a disease-causing parasite In their newest paper, Afasizhev and Afasizheva—along with ...

A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year according to the World Health Organization, yet ...

As molecular biologists at Boston University and as husband and wife, Ruslan Afasizhev and Inna Afasizheva, have worked together for decades. Together, they have published dozens of papers on the ...

Another mRNA vaccine for malaria is on the way. This time, its creators are taking a page from the cancer immunotherapy playbook to make it more effective. In an article published July 20 in Nature ...

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...

The federal government is cutting $500 million in research money for development of mRNA vaccines, which were widely used against the COVID-19 virus. Health Secretary Robert F. Kennedy Jr. said in a ...